FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2966615392> ?p ?o ?g. }

• W2966615392 endingPage "1744" @default.
• W2966615392 startingPage "1721" @default.
• W2966615392 abstract "Abstract Lupus nephritis (LN) leads to chronic kidney disease (CKD) through progressive fibrosis. Mycophenolate inhibits inosine monophosphate dehydrogenase and is a standard treatment for LN. The mammalian or mechanistic target of rapamycin (mTOR) pathway is activated in LN. Rapamycin inhibits mTOR and is effective in preventing kidney transplant rejection, with the additional merits of reduced incidence of malignancies and viral infections. The effect of mycophenolate or rapamycin on kidney fibrosis in LN has not been investigated. We investigated the effects of mycophenolate and rapamycin in New Zealand Black and White first generation (NZB/W F1) murine LN and human mesangial cells (HMCs), focusing on mechanisms leading to kidney fibrosis. Treatment of mice with mycophenolate or rapamycin improved nephritis manifestations, decreased anti-double stranded (ds) DNA antibody titer and reduced immunoglobulin G (IgG) deposition in the kidney. Both mycophenolate and rapamycin, especially the latter, decreased glomerular mTOR Ser2448 phosphorylation. Renal histology in untreated mice showed mesangial proliferation and progressive glomerulosclerosis with tubular atrophy, and increased expression of transforming growth factor β1 (TGF-β1), monocyte chemoattractant protein-1 (MCP-1), α-smooth muscle actin (α-SMA), fibronectin (FN) and collagen. Both mycophenolate and rapamycin ameliorated the histopathological changes. Results from in vitro experiments showed that both mycophenolate and rapamycin decreased mesangial cell proliferation and their binding with anti-dsDNA antibodies. Mycophenolate and rapamycin also down-regulated mTOR and extracellular signal-regulated kinase (ERK) phosphorylation and inhibited fibrotic responses in mesangial cells that were induced by anti-dsDNA antibodies or TGF-β1. Our findings suggest that, in addition to immunosuppression, mycophenolate and rapamycin may reduce fibrosis in LN, which has important implications in preventing CKD in patients with LN." @default.
• W2966615392 created "2019-08-13" @default.
• W2966615392 creator A5015170367 @default.
• W2966615392 creator A5026087691 @default.
• W2966615392 creator A5032695162 @default.
• W2966615392 creator A5044708487 @default.
• W2966615392 creator A5052193047 @default.
• W2966615392 creator A5058287922 @default.
• W2966615392 creator A5065649607 @default.
• W2966615392 creator A5066502573 @default.
• W2966615392 creator A5088908386 @default.
• W2966615392 date "2019-08-01" @default.
• W2966615392 modified "2023-09-30" @default.
• W2966615392 title "Effect of mycophenolate and rapamycin on renal fibrosis in lupus nephritis" @default.
• W2966615392 cites W1544242738 @default.
• W2966615392 cites W1566056826 @default.
• W2966615392 cites W1595570607 @default.
• W2966615392 cites W1687634523 @default.
• W2966615392 cites W1824596188 @default.
• W2966615392 cites W1892960142 @default.
• W2966615392 cites W1909153838 @default.
• W2966615392 cites W1968712129 @default.
• W2966615392 cites W1968902470 @default.
• W2966615392 cites W1969510397 @default.
• W2966615392 cites W1981117687 @default.
• W2966615392 cites W1989321621 @default.
• W2966615392 cites W1995316596 @default.
• W2966615392 cites W1999196721 @default.
• W2966615392 cites W2005953407 @default.
• W2966615392 cites W2009368147 @default.
• W2966615392 cites W2011610612 @default.
• W2966615392 cites W2017838566 @default.
• W2966615392 cites W2017956550 @default.
• W2966615392 cites W2018372725 @default.
• W2966615392 cites W2026237749 @default.
• W2966615392 cites W2029380738 @default.
• W2966615392 cites W2039586517 @default.
• W2966615392 cites W2041926434 @default.
• W2966615392 cites W2043526660 @default.
• W2966615392 cites W2052931193 @default.
• W2966615392 cites W2061904336 @default.
• W2966615392 cites W2062450998 @default.
• W2966615392 cites W2062970882 @default.
• W2966615392 cites W2064380726 @default.
• W2966615392 cites W2066051767 @default.
• W2966615392 cites W2073018303 @default.
• W2966615392 cites W2093458935 @default.
• W2966615392 cites W2097963049 @default.
• W2966615392 cites W2098661610 @default.
• W2966615392 cites W2108872143 @default.
• W2966615392 cites W2109101651 @default.
• W2966615392 cites W2119861401 @default.
• W2966615392 cites W2128091116 @default.
• W2966615392 cites W2128274902 @default.
• W2966615392 cites W2138889351 @default.
• W2966615392 cites W2154768750 @default.
• W2966615392 cites W2157892794 @default.
• W2966615392 cites W2159714906 @default.
• W2966615392 cites W2162406037 @default.
• W2966615392 cites W2165470016 @default.
• W2966615392 cites W2497334009 @default.
• W2966615392 cites W2535435462 @default.
• W2966615392 cites W2593816418 @default.
• W2966615392 cites W2611031776 @default.
• W2966615392 cites W2733767136 @default.
• W2966615392 cites W2764172730 @default.
• W2966615392 cites W2794045308 @default.
• W2966615392 cites W2889573801 @default.
• W2966615392 cites W2890125925 @default.
• W2966615392 cites W2890733322 @default.
• W2966615392 cites W2895750580 @default.
• W2966615392 cites W2903596927 @default.
• W2966615392 cites W4232679340 @default.
• W2966615392 cites W4234713026 @default.
• W2966615392 doi "https://doi.org/10.1042/cs20190536" @default.
• W2966615392 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31358596" @default.
• W2966615392 hasPublicationYear "2019" @default.
• W2966615392 type Work @default.
• W2966615392 sameAs 2966615392 @default.
• W2966615392 citedByCount "20" @default.
• W2966615392 countsByYear W29666153922020 @default.
• W2966615392 countsByYear W29666153922021 @default.
• W2966615392 countsByYear W29666153922022 @default.
• W2966615392 countsByYear W29666153922023 @default.
• W2966615392 crossrefType "journal-article" @default.
• W2966615392 hasAuthorship W2966615392A5015170367 @default.
• W2966615392 hasAuthorship W2966615392A5026087691 @default.
• W2966615392 hasAuthorship W2966615392A5032695162 @default.
• W2966615392 hasAuthorship W2966615392A5044708487 @default.
• W2966615392 hasAuthorship W2966615392A5052193047 @default.
• W2966615392 hasAuthorship W2966615392A5058287922 @default.
• W2966615392 hasAuthorship W2966615392A5065649607 @default.
• W2966615392 hasAuthorship W2966615392A5066502573 @default.
• W2966615392 hasAuthorship W2966615392A5088908386 @default.
• W2966615392 hasConcept C126322002 @default.
• W2966615392 hasConcept C134018914 @default.
• W2966615392 hasConcept C185592680 @default.
• W2966615392 hasConcept C2777390665 @default.

• next